BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Eurofins Product Safety Laboratories Release: New Plant Discovery Demonstrates Impressive Results in Diabetic Study

  June 2, 2008

   · 

  1 min read
• Genetown

  Ahura Scientific’s FirstDefender Now Available Through 2008 CEDAP

  June 2, 2008

   · 

  1 min read
• Biotech Beach

  BIOLASE Technology, Inc. to Present at Upcoming Investment Conferences in New York City

  June 2, 2008

   · 

  1 min read
• BioMidwest

  APP Pharmaceuticals Launches Enhanced Labeling for Heparin Sodium Injection, USP

  June 2, 2008

   · 

  1 min read
• Drug Development

  Phase III Study of Abbott Laboratories’ Investigational TriLipix(TM) in Combination With AstraZeneca Pharmaceuticals LP’s CRESTOR(R) Meets Primary Endpoints on Key Lipids

  June 2, 2008

   · 

  4 min read
• Drug Development

  Sunesis Pharmaceuticals, Inc. Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th American Society of Clinical Oncology Annual Meeting

  June 2, 2008

   · 

  6 min read
• Business

  etrials Announces CFO Resignation

  June 2, 2008

   · 

  1 min read
• Drug Development

  Data To Be Presented at American Society of Clinical Oncology Supports Potential of Peregrine Pharmaceuticals, Inc.'s Cotara(R) for the Treatment of Brain Cancer

  June 2, 2008

   · 

  6 min read
• Drug Development

  Apthera, Inc.'s NeuVax™ Produces Delays in Recurrence in High-Risk HER2-Positive Prostate Cancer Patients

  June 2, 2008

   · 

  1 min read
• BioMidwest

  The International Myeloma Foundation Says New Studies Show Longer Survival for Myeloma Patients and Improved Response to Treatments

  June 2, 2008

   · 

  1 min read